Orexo AB (ORXOF) Enters An Exclusive Reimbursement Agreement With Unitedhealth Group And Optumrx For ZUBSOLV®
3/12/2014 8:52:02 AM
UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (STO:ORX), the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.
Help employers find you! Check out all the jobs and post your resume.
comments powered by